- $50.93m
- $133.63m
- CNY12.56bn
Annual income statement for 111, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 12,426 | 13,517 | 14,948 | 14,401 | 12,556 |
| Cost of Revenue | |||||
| Gross Profit | 621 | 840 | 849 | 829 | 723 |
| Selling / General / Administrative Expenses | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 13,068 | 13,888 | 15,298 | 14,399 | 12,558 |
| Operating Profit | -642 | -371 | -350 | 2.11 | -2.38 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -621 | -376 | -353 | -20.7 | -22.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -621 | -376 | -353 | -20.8 | -22.5 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -670 | -417 | -393 | -64.7 | -66.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -670 | -417 | -393 | -64.7 | -66.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -40.4 | -25 | -23.3 | -0.377 | -0.382 |